Trending Articles

article thumbnail

AI-Powered Pharma: How Artificial Intelligence is Transforming Drug Development,

Pharma IQ

Discover how AI is transforming pharmaceutical development, from drug discovery to clinical trials, supply chain resilience, and personalised medicine.

130
130
article thumbnail

Bayer reveals phase 3 data for improved MRI contrast agent

pharmaphorum

Bayer is close to filing a new MRI contrast agent that can reduce levels of gadolinium, which can have health and environmental consequences.

88
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA sets June date for Gilead's twice-yearly HIV PrEP

pharmaphorum

Gilead's already dominant position in HIV PrEP could be extended if the FDA approves a new twice-yearly injectable product later this year

FDA 117
article thumbnail

Biogen and Stoke Therapeutics to commercialise Dravet syndrome treatment

Pharmaceutical Technology

Biogen has entered a collaboration with Stoke Therapeutics to develop and commercialise zorevunersen to treat Dravet syndrome.

111
111
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

How Tampa General Hospital’s Partnership with Palantir Is Shortening Its Innovation Timelines

MedCity News

Palantir is poised to have a significant impact on the healthcare sector, said Scott Arnold, CIO and chief of innovation at Tampa General Hospital. Partnering with the tech company has allowed Tampa General to “solve problems in hours and days instead of months and years,” he remarked. The post How Tampa General Hospitals Partnership with Palantir Is Shortening Its Innovation Timelines appeared first on MedCity News.

More Trending

article thumbnail

UK study highlights importance of GP data in understanding atrial fibrillation

PharmaTimes

The common heart condition affects approximately 1.

83
article thumbnail

SMA treatment with Evrysdi 'could start prenatally'

pharmaphorum

SMA treatment with Evrysdi 'could start prenatally' Phil.

98
article thumbnail

Amazon joins forces with Memorial Sloan Kettering for AI-powered drug discovery

Pharmaceutical Technology

MSK plans to speed up early-stage drug development by using AWS Drug Discovery Workbench to screen potential candidates.

109
109
article thumbnail

Prioritizing Care That Cures – Fighting the Epidemic With Opioid Treatment Programs

MedCity News

Policymakers should recognize the advantages of this multi-faceted care model and ensure legislative and regulatory environments allow for its continued growth. The post Prioritizing Care That Cures Fighting the Epidemic With Opioid Treatment Programs appeared first on MedCity News.

article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Anthropomorphizing AI: Dire Consequences of Mistaking Human-Like for Human Have Already Emerged

Copyright Clearance Center

The post Anthropomorphizing AI: Dire Consequences of Mistaking Human-Like for Human Have Already Emerged appeared first on Copyright Clearance Center.

96
article thumbnail

Kennedy’s MAHA agenda is tackling ‘conflicts of interest’ — and could take aim at FDA adcomms

PharmaVoice

Health agency job cuts and a newly-established MAHA commission leave many unanswered questions about potential reforms and impact on drug approvals.

FDA 81
article thumbnail

Poolbeg slumps as Hookipa merger is called off

pharmaphorum

A proposed merger of the UK's Poolbeg with Austrian biotech Hookipa has been called off after the latter abruptly withdrew from negotiations.

95
article thumbnail

Pharma and medtech industry reacts to FDA, CDC and NIH job cuts

Pharmaceutical Technology

The FDA, NIH and CDC has cut 5,200 probationary staff in a job cull across the HHS over the Valentine's Day weekend.

FDA 106
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz Segment

MedCity News

Thermo Fisher Scientific agreed to acquire the Purification and Filtration business of 3M spinoff Solventum. Filters and membranes from this business segment are used globally in applications such as biopharmaceutical manufacturing. The post Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz Segment appeared first on MedCity News.

article thumbnail

AI Rights Reservation: Human Readable is Machine Readable — An Interview with Haralambos (“Babis”) Marmanis

Copyright Clearance Center

The post AI Rights Reservation: Human Readable is Machine Readable An Interview with Haralambos (Babis) Marmanis appeared first on Copyright Clearance Center.

84
article thumbnail

Rishi Sunak joins Prostate Cancer Research as an ambassador

PharmaTimes

Former UK PM advocates for national screening programme

74
article thumbnail

Semaglutide shortage ends as FDA sets deadline for compounders

Pharmaceutical Technology

With Novo Nordisks blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed for now.

FDA 105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Future Family Guarantees ‘Baby or Your Money Back’ with New Nationwide IVF Insurance

MedCity News

Future Family launched a nationwide IVF insurance product on Wednesday. If families don’t achieve a live birth after two cycles of IVF, they can get their money back. The post Future Family Guarantees ‘Baby or Your Money Back’ with New Nationwide IVF Insurance appeared first on MedCity News.

article thumbnail

Merck, Lilly launch manufacturing R&D consortium to help ‘bolster’ U.S. production

PharmaVoice

The Young Institute Pharmaceutical Manufacturing Consortium will research and develop new production technologies.

article thumbnail

ICR researchers develop blood test to uncover how childhood tumours adapt

PharmaTimes

It is hoped that the approach will lead to more targeted treatments for childhood cancers

Leads 71
article thumbnail

Ex-CDER chief Cavazzoni rejoins Pfizer as CMO

pharmaphorum

In a move that will raise eyebrows in Washington, Pfizer has hired former FDA director Patricia Cavazzoni as its new chief medical officer

FDA 95
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Pfizer shelves haemophilia gene therapy Beqvez amid low demand

Pharmaceutical Technology

Pfizer said resources will be directed to its other haemophilia gene therapy Hympavzi.

101
101
article thumbnail

How to Improve Employee Benefits While Reducing Insurance Costs

MedCity News

[Sponsored] Balancing healthcare benefits and insurance costs requires research. From becoming a Difference Card member to offering wellness resources, there are many ways to improve healthcare at low cost. The post How to Improve Employee Benefits While Reducing Insurance Costs appeared first on MedCity News.

article thumbnail

The Biosimilars Landscape Through the Eyes of an Economist

Pharmaceutical Commerce

James D. Chambers, PhD, MPharm, MSc, professor of medicine at the Tufts Medical Center Institute for Clinical Research and Health Policy Studies, dives into why biosimilars contribute to a reduction in cost and increase in patient access, while highlighting challenges to adoption.

article thumbnail

Microbiotica unveils new data on MB097 at AACR IO meeting

PharmaTimes

Data presented in Los Angeles showcases therapys potential

62
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Evidence builds behind Regeneron's deafness gene therapy

pharmaphorum

Ten out of 11 children with congenital deafness treated with a gene therapy developed by Regeneron have seen "notable" improvements in hearing

85
article thumbnail

J&J sues Samsung Bioepis over ‘surreptitious’ breach of Stelara biosimilar contract

Pharmaceutical Technology

Samsung Bioepis has now allegedly sub-licensed its Stelara biosimilar rights to a health conglomerate, breaching a previous settlement.

99
article thumbnail

The HRT Club Launches to Expand Access to Hormonal Care

MedCity News

The HRT Club provides access to a network of over 700 healthcare providers who can prescribe hormone replacement therapies. The post The HRT Club Launches to Expand Access to Hormonal Care appeared first on MedCity News.